发明名称 |
TGFB TYPE II-TYPE III RECEPTOR FUSIONS |
摘要 |
Certain embodiments are directed to novel heterotrimeric fusions in which the ectodomain of the TGF-β type II receptor (TβP?II) is coupled to the N- and C-terminal ends of the endoglin-domain of the TGF-β type III receptor (TpRIIIE). Certain embodiments are directed to novel heterotrimeric polypeptides in which the ectodomain of the TGF-β type II receptor (TI3RII) is coupled to the N- and C-terminal ends of the endoglin-domain (E domain) of the TGF-β type III receptor (TI3RIII). This trimeric receptor, known as RER, can bind all three TGF-β isoforms with sub-nanomolar affinity and is effective at neutralizing signaling induced by all three TGF-β isoforms, but not other ligands of the TGF-β superfamily, such as activins, growth and differentiation factors (GDFs), and bone morphonogenetic proteins (BMPs). |
申请公布号 |
US2015045299(A1) |
申请公布日期 |
2015.02.12 |
申请号 |
US201314387901 |
申请日期 |
2013.03.28 |
申请人 |
THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM |
发明人 |
Andrew Hinck;Sun Luzhen;Zwieb Christian |
分类号 |
C07K14/495 |
主分类号 |
C07K14/495 |
代理机构 |
|
代理人 |
|
主权项 |
1. A heterotrimeric fusion protein comprising:
(a) an amino terminal segment comprising a first TGFβ binding domain of TGFβ receptor type II, (b) a central segment comprising a endoglin-domain of TGFβ receptor type III, and (c) a carboxy terminal segment comprising a second TGFβ binding domain of TGFβ receptor type II. |
地址 |
Austin TX US |